Medication info
Double Star Tablet 80/5 mg

Double Star Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
TDS Pharm Co., Ltd.
Appearance
Biconvex oval double tablet with white and light blue coloring
Packaging
30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900624 · Approved 2019.01.24 · Insurance code 679801770

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Children: Administration of this medicine is not recommended for children 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
TDS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension refers to a continuously high blood pressure condition, and this medication is used when blood pressure is not sufficiently controlled with either telmisartan or amlodipine monotherapy. These medications help lower blood pressure and reduce the risk of cardiovascular disease. This can effectively prevent complications from hypertension and maintain health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Children: Administration of this medicine is not recommended for children 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication can cause serious damage to the fetus if taken during pregnancy, especially in the second and third trimesters, thus it should not be taken by pregnant women or women who may become pregnant. This medication should not be given to patients who are allergic to the active substance or similiar substances, pregnant women, nursing mothers, patients with severely impaired liver function, and those with serious heart or blood pressure issues. Patients with weakened liver function, gastrointestinal conditions, kidney problems, and the elderly should be particularly cautious when using this medication and must follow a doctor's instructions. Taking this medication may cause side effects such as dizziness or swelling, so if symptoms are severe or persistent, immediate consultation with medical personnel is required. This medication has blood pressure-lowering effects, which may lead to symptoms of hypotension, particularly in dehydrated patients or those taking diuretics. There is a risk of increased potassium levels in the blood, so if taking potassium-rich medications or supplements, it should be done under a doctor's guidance. Patients with impaired kidney function should have their kidney function and electrolyte levels regularly checked before and after taking this medication. This medication may interact with other blood pressure medications or certain drugs, so if other medications are being taken, it is essential to inform medical personnel. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. This medication contains sorbitol, so patients with fructose intolerance should not take it. In case of overdose, serious symptoms such as hypotension, dizziness, and heart rate changes may occur, requiring immediate visit to a medical institution; treatment will be based on symptoms. This medication is not recommended for use in children as its safety and efficacy have not been established.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste abnormalities
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • lumbago
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • mesenteric vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that can block light and air, and it is recommended to keep it at room temperature between 1°C and 30°C. This storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Biconvex oval double tablet with white and light blue coloring

Package unit

30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.